Mar 25, 2026, 9:52 PM IST RRP Defense - Announcement under Regulation 30 (LODR)-Press Release / Media Release Mar 07, 2026, 12:58 AM IST RRP Defense - Announcement under Regulation 30 (LODR)-Change in ...

This beginner-friendly tutorial shows how to create clear, interactive graphs in GlowScript VPython. You’ll learn the basics of setting up plots, graphing data in real time, and customizing axes and ...

Deadline’s Read the Screenplay series spotlighting the scripts behind the awards season’s most talked-about movies continues with Warner Bros‘ Weapons. Writer-director Zach Cregger described the ...

BASH is a Unix shell and command language which can run Shell Script files. You do not need to install Ubuntu or any other Linux Distros unless your scripts need the ...

RRP Semiconductor has stunned Indian markets with a staggering 61,848% surge in its share price over just 18 months — but now, stock exchange BSE is stepping in with a red flag for investors. From ₹15 ...

The Bombay Stock Exchange (BSE) has issued a cautionary alert to investors after observing an extraordinary rise in the share price of RRP Semiconductor Limited, which has jumped from Rs 15 in April ...

RRP Semiconductor on October 14 clarified former cricketer Sachin Tendulkar hasn't subscribed to any of its shares and is not its brand ambassador. The clarification comes in wake of "unprecedented ...

While sire Not This Time is turning heads at a dizzying rate with his racetrack progeny, Sibelius , a son from his first crop, is poised to bring his father additional notoriety at the Retired ...

On 14 August 2025, the US Food and Drugs Administration (FDA) approved Precigen’s Papzimeos (zopapogene imadenovec) for recurrent respiratory papillomatosis (RRP) - the first FDA-approved therapy for ...

Tumors caused by recurrent respiratory papillomatosis are benign, but that doesn’t mean they are not serious. In this rare disease, growths form in the respiratory tract that restrict a patient’s ...

In related developments, JMP Securities maintained its Market Outperform rating and $6 price target on Precigen Inc., following a patient advocacy event for RRP. The event, which was hosted by the ...